Late-onset neurodegenerative diseases--the role of protein insolubility.
about
Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model miceDorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosisEvaluation of traditional medicines for neurodegenerative diseases using Drosophila modelsConformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregationTwo-dimensional infrared correlation spectroscopy study of sequential events in the heat-induced unfolding and aggregation process of myoglobin.Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factorsProtein misfolding and disease; protein refolding and therapy.Learning cell biology as a team: a project-based approach to upper-division cell biologyProgrammed cell death in amyotrophic lateral sclerosisDecreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain.Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.α -Synuclein Modification in an ALS Animal Model.Effects of urea and acetic acid on the heme axial ligation structure of ferric myoglobin at very acidic pH.One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: conformational heterogeneity of alpha-synuclein.Neuroprotection in Parkinson's disease: love story or mission impossible?The emerging utility of animal models of chronic neurodegenerative diseases.Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.
P2860
Q24544265-16794113-A2F5-4D73-9B2D-E6352BED4931Q24685507-8724512E-6D75-4130-BA25-6AE87133EDBEQ27027455-3C130C69-AECF-46C6-855D-06907C2464FDQ28367378-8D93B47F-D564-4093-BA48-39937450658FQ30503511-0DC8C247-E335-407F-A3DE-A746B7601197Q33371063-E9C1EB06-BDF9-45C2-859F-244F852BCFF7Q34286115-70D040B1-6D89-4CC3-B69C-2A2D27AB768DQ34741685-81ADDF32-D3EA-4024-B90B-34F334BE845DQ34831541-41A09287-9EEC-4370-A04D-A24503979DA2Q36772901-D2D41D79-497B-4760-A83E-4A7B1470EB7AQ37253310-7DC666E7-A7DE-43B5-A570-FF3E8023BAA6Q37351380-BF405F99-4A2E-47E2-8FDE-7218F1B2D16FQ38609997-F297582B-F48D-44CE-8F52-F449C31F6DF4Q41141295-D9FE0632-C029-4136-A403-A780F1B77F06Q41969333-22C2AEA9-E3E2-48EA-A7B0-EBAF3BE502C4Q42208600-C7D821CE-D62A-4951-80B0-63A743A7BF27Q43256880-74FBB8D5-0C17-4695-9E82-03E4B473752DQ43265626-EFC5E64A-83D9-4479-8F46-0825C9B91ECDQ45884689-A7CBB3B5-B7BF-4220-B63C-DD5653A3269CQ50764411-F839530F-D2E2-47BB-BBC2-BD21499D8971
P2860
Late-onset neurodegenerative diseases--the role of protein insolubility.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Late-onset neurodegenerative diseases--the role of protein insolubility.
@ast
Late-onset neurodegenerative diseases--the role of protein insolubility.
@en
type
label
Late-onset neurodegenerative diseases--the role of protein insolubility.
@ast
Late-onset neurodegenerative diseases--the role of protein insolubility.
@en
altLabel
Late-onset neurodegenerative diseases-the role of protein insolubility
@en
prefLabel
Late-onset neurodegenerative diseases--the role of protein insolubility.
@ast
Late-onset neurodegenerative diseases--the role of protein insolubility.
@en
P2860
P1433
P1476
Late-onset neurodegenerative diseases--the role of protein insolubility.
@en
P2093
Johnson WG
P2860
P304
P356
10.1046/J.1469-7580.2000.19640609.X
P478
196 ( Pt 4)
P577
2000-05-01T00:00:00Z